What could be causing my low libido, erectile dysfunction (ED), decreased semen volume, and thicker semen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Low Libido, Erectile Dysfunction, and Decreased/Thickened Semen Volume

Immediate Diagnostic Workup

You need morning total testosterone measured on two separate occasions, along with FSH and prolactin levels, as this constellation of symptoms strongly suggests hypogonadism. 1

  • Measure morning total testosterone on two separate days, as testosterone levels fluctuate and diagnosis requires persistent deficiency 1
  • Check FSH to distinguish primary hypogonadism (elevated FSH) from secondary hypogonadism (low/normal FSH), which is potentially reversible 1
  • Measure serum prolactin in all men with reduced libido and erectile dysfunction combined with low testosterone, as hyperprolactinemia causes this exact symptom constellation 1
  • If total testosterone is borderline, check SHBG levels, since elevated SHBG reduces bioavailable testosterone and can cause functional hypogonadism despite normal total testosterone 1

Physical Examination Findings to Document

  • Palpate bilaterally for vas deferens to rule out congenital bilateral absence of vas deferens (CBAVD) 2
  • Assess testicular size and consistency—normal-sized testes suggest obstruction while atrophic testes indicate spermatogenic failure 2
  • Perform digital rectal examination to assess prostate size and consistency 2
  • Examine for palpable varicoceles, as treatment of clinical varicoceles improves semen parameters 2

Semen Analysis and Additional Testing

  • Check semen pH, as acidic semen (pH <7.0) with low volume strongly suggests ejaculatory duct obstruction or CBAVD 2, 3
  • Perform post-ejaculatory urinalysis when volume <1 mL (except in bilateral vasal agenesis or hypogonadism) to diagnose retrograde ejaculation 2
  • Measure semen volume—normal is ≥1.4 mL; volumes below this threshold require investigation for structural causes 2

Medication Review for Iatrogenic Causes

  • Review all medications for drugs that suppress the hypothalamic-pituitary-gonadal axis, such as opiates, glucocorticoids, anabolic steroids, and GnRH agonists/antagonists 1
  • 5α-reductase inhibitors (finasteride, dutasteride) commonly cause reduced libido, erectile dysfunction, ejaculation disorders, and decreased semen volume 4
  • Alpha-1 blockers do not affect libido but cause ejaculatory dysfunction, especially tamsulosin and silodosin 4
  • Finasteride 5 mg/day is associated with reduced semen volume 2

Interpretation of Hormone Results and Next Steps

If Testosterone is Low with Low/Normal FSH (Secondary Hypogonadism)

  • Order MRI of the pituitary if prolactin is elevated to evaluate for prolactinoma or other pituitary masses 1
  • Treat the underlying cause of hyperprolactinemia, such as discontinuing prolactin-elevating medications or treating prolactinoma with dopamine agonists 1
  • Hyperprolactinemia directly suppresses libido and causes erectile dysfunction independent of testosterone levels 1

If Testosterone is Low with Elevated FSH (Primary Hypogonadism)

  • This indicates testicular failure and is generally not reversible 1
  • Testosterone replacement therapy is appropriate if fertility is not desired 1

Structural Causes of Low Semen Volume

Ejaculatory Duct Obstruction (EDO)

  • EDO presents with acidic semen (pH <7.0), volume <1.4 mL, azoospermia or severe oligospermia, normal testosterone, and palpable vas deferens 1, 2
  • Order TRUS or pelvic MRI only when clinical criteria for EDO are met—do not perform as part of routine initial evaluation 2, 3
  • Transurethral resection of ejaculatory ducts (TURED) is the definitive treatment for confirmed EDO on TRUS or MRI showing dilated seminal vesicles and ejaculatory ducts 2, 3

Congenital Bilateral Absence of Vas Deferens (CBAVD)

  • CBAVD can be diagnosed by physical examination alone when vas deferens are not palpable bilaterally 3
  • No medical or surgical treatment restores ejaculatory volume; proceed directly to sperm retrieval (TESE/MESA) with ICSI for fertility 2, 3
  • CFTR gene testing for the female partner is mandatory before proceeding with assisted reproduction 2, 3

Varicocele

  • Treatment is indicated for palpable varicoceles with abnormal semen parameters 2, 3
  • Varicocelectomy improves semen parameters and may restore sperm in ejaculate for men with azoospermia 2, 3
  • Do not treat subclinical (non-palpable) varicoceles, as this does not improve semen parameters or fertility rates 2, 3

Treatment Algorithm Based on Etiology

If Hypogonadism is Confirmed and Fertility is NOT Desired

  • Testosterone replacement therapy normalizes libido, improves erectile function, and enhances quality of life in men with secondary hypogonadism without fertility concerns 1
  • Intramuscular formulations are preferred over transdermal formulations when initiating testosterone treatment, as costs are considerably lower and clinical effectiveness and harms are similar 4
  • Reevaluate symptoms within 12 months and periodically thereafter; discontinue testosterone treatment if there is no improvement in sexual function 4

If Hypogonadism is Confirmed and Fertility IS Desired

  • Never initiate testosterone replacement therapy in men desiring fertility, as it suppresses spermatogenesis and can cause azoospermia 1, 2
  • Refer to reproductive endocrinology for gonadotropin therapy or other fertility-preserving treatments 1

If Testosterone is Normal

  • Consider tadalafil 5 mg daily, the only PDE5 inhibitor licensed for treatment of male lower urinary tract symptoms and erectile dysfunction 4
  • Tadalafil decreased sperm concentrations in studies of 10 mg for 6 months and 20 mg for 9 months, but this effect was not seen in the study of 20 mg for 6 months 5
  • Tadalafil had no adverse effect on mean concentrations of testosterone, luteinizing hormone, or follicle stimulating hormone 5
  • Psychosexual therapy may be used in conjunction with physical therapies and shows successful outcomes in 50-80% of patients 4

Lifestyle and Risk Factor Modification

  • Obesity decreases testosterone and SHBG, worsens erectile function, and is a modifiable factor that worsens sexual function 1
  • Smoking is associated with reduced fertility and erectile dysfunction; cessation is recommended 1
  • Alcohol consumption results in slightly lower semen volume and slightly poorer sperm morphology 2
  • Anabolic steroid use is associated with reduced fertility and should be discontinued 2

Genetic Testing Before Assisted Reproduction

  • Karyotype testing is mandatory for azoospermia or severe oligospermia (<5 million/mL) 1, 2, 3
  • Y-chromosome microdeletion analysis is required for azoospermia or sperm concentration <1 million/mL 1, 2, 3
  • Genetic counseling should precede ICSI, as genetic abnormalities may be transmitted to offspring 2, 3

Critical Pitfalls to Avoid

  • Do not attribute low semen volume to stress alone—stress is associated with reduced sperm progressive motility but has no association with semen volume 2
  • Do not use ultrasound to hunt for subclinical varicoceles—only palpable varicoceles benefit from treatment 2, 3
  • Do not delay genetic testing—results impact counseling and treatment decisions before proceeding with assisted reproduction 2, 3
  • Do not routinely order TRUS or pelvic MRI as part of initial evaluation—reserve for cases with clear clinical suspicion of EDO 2, 3
  • A history of decreased libido and/or testicular atrophy on physical examination cannot predict hypogonadism, so laboratory testing is mandatory 6

References

Guideline

Evaluation and Management of Male Hypogonadism and Sexual Dysfunction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Evaluation and Treatment of Reduced Arousal and Semen Volume

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Low Semen Volume

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.